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1. Introduction 
BCDH complex in extracts of rat heart, kidney, 
liver and skeletal muscle mitochondria is inactivated 
by ATP [l-5]. Inactivation by ATP is inhibited by 
ketoleucine, reversed by PDHP phosphatase prepara- 
tions [ 1,3,5] and correlated with incorporation of 
32P from [y-32P]ATP into a protein of M, 48 000 
assumed to be the a-chain of BCDH [5-71. Inactiva- 
tion, 32P incorporation and reactivation has been 
shown in mitochondria [ 1,3,5-7 91 and interconver- 
sion has been shown in perfused rat heart [3]. 
Further progress is hampered by the lack of a bulk 
source of purified BCDH complex inactivated by ATP. 
Ox kidney mitochondria is the most convenient bulk 
source but in [8] no inactivation of ox kidney cdm- 
plex by ATP was found. Although we have confirmed 
these findings with procedure A in [8] it seemed 
important to reinvestigate the ox kidney complex 
using different methods of purification. We describe 
here phosphorylation and inactivation by ATP of puri- 
fied ox kidney BCDH complex free of PDH complex. 
2. Experimental 
Sources of materials were as in [5,10,1 l]. BCDH 
complex was assayed spectrophotometrically [5] on 
samples containing 5-10 munits (prior to ATP inac- 
Abbreviations: BCDH, branched chain 2+xoacid dehydrogen- 
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tivation). PDH complex was assayed likewise with 
1 mM pyruvate. Protein bound 32P was assayed on 
paper squares [ 111. SDS-PAGE and autoradiography 
of gels was as in [5]. Buffers: (A) 30 mM potassium 
phosphate/5 mM DTT/S mM EGTAlO.2 mM TPP/I% 
(v/v) ox serum/5% (v/v) Triton/pH 7.5 ; (B) as (A) 
omitting Triton but with 0.25 M NaCl. For ATP inac- 
tivation MgC12 (to 10 mM), oligomycin B (to 25 pg/ 
ml) and ATP (to 1 mM unless given) were added; incu- 
bations were at 30°C with controls lacking ATP. 
Ox kidney cortex mitochondria were isolated from 
an homogenate (Atomix homogeniser 4 X 1.5 s bursts) 
in 0.25 M sucrose/5 mM Tris-HC1/2 mM EGTA/ 
pH 7.5, by centrifugation at 800 X g for 20 min (to 
remove debris) and 31 800 X g for 20 min (to pack 
mitochondria). The 800 X g pellet was re-extracted 
once. Mitochondria were resuspended and repelleted in 
sucrose medium 3X. Extracts were prepared by freez- 
ing (liquid N,) and thawing (3O’C) 3X in buffer A 
(50 mg protein/ml) and clarified at 49 600 X g for 
15 min. 
3. Results and discussion 
The objective was to prepare BCDH complex free 
of PDH complex that was inactivated by phosphoryl- 
ation with ATP. Criteria of purification were: activity 
ratio (BCDH complex/PDH complex); absence of 
PDH complex subunits on SDS-PAGE; absence of 
32P in a-subunit of PDH on SDS-PAGE; protein was 
not assayed. Purified BCDH complex free of PDH 
complex oxidises pyruvate [8]; the expected activity 
ratio was 6: 1 .A4,-Values for the subunits of the 
bovine kidney BCDH and PDH complexes are given in 
[8,12]. The Mr of the BCDH a-subunit is 46 000 and 
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that of the PDH a-subunit 41 000. In what follows, 
results of ATP inactivation and of controls are given 
as the % change in BCDH activity/time of incubation, 
i.e., a negative change is loss of activity. Results are 
means of 2 ohs., which on average differed by <6% of 
their mean. 
3.1 .Pilot experiments 
BCDH complex in mitochondrial extracts was inac- 
tivated by 0.5 mM ATP (ATP, -32%/l 5 min; control 
+O%). The results differ from those in [8] (no inactiva- 
tion) perhaps because ATP hydrolysis was minimised 
by oligomycin B and low protein concentration 
(1 mg/ml) [5,6]. After precipitation by centrifugation 
at 157 000 X g for 2 h and solution in buffer B inac- 
tivation by ATP was retained (ATP, -SO%/30 min; 
control +4%) and was associated with incorporation 
of “P from [Y-~*P]ATP into the o-chain of BCDH 
(fig.lA). Ketoleucine inhibited inactivation(not given) 
and incorporation (fig.lB). BCDH complex precipi- 
tated with 5% PEG at pH 6.4 and taken up in modi- 
fied buffer B (50 mM MOPS (pH 7) in place of phos- 
phate) was not inactivated by ATP (ATP, -1 l%/ 
30 min; control -14%). MOPS buffer inhibited inac- 
tivation. Dilution by lo-fold with buffer B restored 
A B C D EF 
Fig.1. Autoradiographs of gels after SDS-PAGE of prepara- 
tions of BCDH complex incubated with [-Y-~*P]ATP: (A,C,E) 
ATP alone; (B,D,F) with 2 mM ketoleucine + ATP; (A,B) 
157 000 X g pellet from mitochondrial extracts taken up in 
buffer B; BCDH complex, 0.90 units/ml; 1 mM [Y-~‘P]ATP, 
440 dpm/pmol. (a) Mr 462 000 (BCDHor); (b) Mr 42 200 
(PDHo). (CD) 157 000 X g pellet from fraction obtained with 
2% PEG at pH 7 5 ; BCDH complex, 0.56 units/ml; 0.3 mM 
[y-‘aP]ATP; 2300 dpm/pmol. (E,F) Fraction obtained by pre- 
cipitation at pH 6.4; BCDH complex, 1 .O units/ml; 0.3 mM 
[@*P]ATP; 2300 dpm/pmol. 
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inactivation (ATP, -9 1%/30 min; control 20%); 
lo-fold dilution in MOPS buffer B did not (ATP, 
-1 I%/30 min; control +7%). Chromatography on 
hydroxyapatite [7] was unsuccessful as separation 
from PDH complex was incomplete and ATP inacti- 
vation was lost. Precipitation of BCDH complex at 
pH 62 [S] led to loss of inactivation by ATP. It was 
then discovered that omission of TPP and ox serum 
from buffer B resulted in precipitation of BCDH com- 
plex, at pH 6.4; the preparation was inactivated by 
ATP and apparently free of PDH complex. The proto- 
col of two successful preparations was as follows; all 
operations were at 4°C. 
3 2. Putification of BCDH complex 
Fresh ox kidney cortex (650 g) gave 25 * 2 g mito- 
chondrial protein and mitochondrial extract contained 
96 + 6.5 units of BCDH complex (mean + SEM for 
7 obs.). The activity ratio (BCDH complex/PDH com- 
plex) was <0.07 (because of lactate dehydrogenase, 
PDH complex is under-estimated). MgCl, was added 
to 10 mM and BCDH complex precipitated at pH 7.5 
with 0.04 vol. 50% (w/v) PEG, and separated at 
49 600 X g for 15 min, taken up in buffer B, and clar- 
ified after 60 min by centrifugation. Recovery of 
BCDH complex was 59 f 5.3 (6 obs.); activity ratio 
was 2.7 f 0.23 (6 obs.); the complex was inactivated 
by ATP (ATP, -39%/20 min; control -7%). The solu- 
tion was centrifuged twice at 100 000 X g for 15 min; 
this removed brown pigmented material. The recovery 
of BCDH complex (supernatant) was 75 + 5% (4 obs.) 
the activity ratio was 3.0 + 0.25 (4 obs.). 
The BCDH complex was precipitated and separated 
from proteins of lower M, (including lactate dehydro- 
genase) by centrifugation at 157 000 X g for 2 h, 
taken up in phosphate/DTT/EGTA/pH 7.5 and clari- 
fied by centrifugation (100 000 X g/ 10 min). The 
recovery of BCDH complex (supernatant) was 76%; 
the activity ratio was 2.9 + 0.9 (4 obs.). BCDH com- 
plex was inactivated by ATP (ATP, - 1 OO%/ 10 min; 
control kO%). With [y-32P]ATP, 32P was incorporated 
into the o-chains of BCDH and PDH (fig.lC). Keto- 
leucine inhibited 32P incorporation into the BCDH 
a-chain (fig.lD) and inactivation (not given). SDS- 
PAGE showed subunits of both complexes (not given). 
The solution was adjusted to pH 6.8, insoluble mate- 
rial removed and discarded after 10 min (49 600 X g/ 
10 min), and the pH of the supernatant adjusted to 
6.4. After 10 min the precipitate was collected 
(49 600 X g/10 mm) and taken up in phosphate/DTT/ 
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Fig.2. Inactivation and incorporation of szP into purified ox 
kidney BCDH complex (1 unit/ml) incubated at 30°C with 
[@*P]ATP (0.3 mM; 323 dpm/pmol). At the times shown in 
(a) 25 ~1 samples were taken for assay of 3zP in protein and 
two 5 ~1 samples for assay of BCDH complex activity with 
ketoleucine and pyruvate. Controls lacking ATP showed no 
change in activities (not given). Each point is mean of 2 obs. 
Note inverted ordinate in (b). 
EGTA/pH 7.5 . The recovery of BCDH complex was 
23% (overall yield 6%); the activity ratio (ketoleucine/ 
pyruvate) was 6.0-7.9. SDS-PAGE showed the 3 
subunits of the BCDH complex together with low M, 
material near the dye front; subunits of the PDH com- 
plex were absent (not given). 
3 3. Phospholylation and inactivation of purified 
BCDH complex 
Pilot experiments showed inactivation of BCDH 
complex by 0.3 mM ATP (ATP, -97%/3 min, -lOO%/ 
6 min; control -S%, -5%). 
SDS-PAGE after incubation for 20 min with 
0.3 mM [y-‘*P]ATP showed a single band of 32P cor- 
responding to the a-chain of BCDH; this incorpora- 
tion was inhibited by 2 mM ketoleucine (fig.lE,F). 
Fig2(a) shows the time course of inactivation and of 
32P incorporation into protein. The pyruvate dehydro- 
genase activity (assumed to be due to oxidation of 
pyruvate by BCDH complex) was lost concurrently 
with BCDH complex activity. Inactivation of BCDH 
complex was 94% in 2.5 min; activity with pyruvate 
fell to the limit of detection in 1 min. Inactivation of 
BCDH complex (ketoleucine) was correlated linearly 
with 32P incorporation as shown in fig.2(b) (note 
inverted ordinate). Inactivation was apparently first 
order as shown in fig2(c) and the rate constant was 
-0.904 + 0.032 min-’ (mean f SEM for 6 obs.; corre- 
lation coefficient, r = 1 .OO). Lastly, inactivation by 
ATP was reduced from 94% (in 2.5 min) to 20% by 
2 mM ketoleucine. 
4. Conclusions 
The method of purification described has yielded 
BCDH complex which is rapidly phosphorylated and 
inactivated by ATP and which presumably contains a 
kinase associated with the complex. The overall yield 
of complex was poor (<6%) and much less than that 
given in [g] (4410%). Success in obtaining BCDH 
complex inactivated and phosphorylated by ATP 
appears to be due to avoidance of MOPS buffer and 
to precipitation at pH 6.4 in the absence of TPP as 
opposed to precipitation at pH 6.2 in the presence of 
TPP. Further refinement may improve the yield but a 
suitable preparation for more detailed studies of phos- 
phorylation/dephosphorylation and its regulation is 
now available. 
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